KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862,359 | -63.8% | 5,100 | -53.6% | 0.00% | -71.4% |
| Q2 2023 | $2,385,350 | -34.2% | 11,000 | -44.9% | 0.01% | -12.5% |
| Q1 2023 | $3,625,898 | -44.7% | 19,962 | -40.2% | 0.01% | -57.9% |
| Q4 2022 | $6,557,402 | -11.8% | 33,371 | +0.9% | 0.02% | -17.4% |
| Q3 2022 | $7,436,000 | +7.4% | 33,058 | -39.6% | 0.02% | 0.0% |
| Q2 2022 | $6,924,000 | +212.7% | 54,723 | +213.4% | 0.02% | +228.6% |
| Q1 2022 | $2,214,000 | +106.0% | 17,459 | +112.9% | 0.01% | +133.3% |
| Q4 2021 | $1,075,000 | +326.6% | 8,200 | +290.5% | 0.00% | +200.0% |
| Q1 2021 | $252,000 | -82.3% | 2,100 | -85.0% | 0.00% | -83.3% |
| Q4 2020 | $1,423,000 | +611.5% | 14,000 | +677.8% | 0.01% | +500.0% |
| Q2 2020 | $200,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |